[Moclobemide].
Gleiter
C
C
Abteilung Klinische Pharmakologie Universität, Göttingen.
Volz
H P
HP
D000928:Antidepressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001549:Benzamides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy; D003866:Depressive Disorder / Q000188:drug therapy; D006801:Humans; D007527:Isoenzymes / Q000378:metabolism; D020912:Moclobemide; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D010919:Placebos; D014191:Tranylcypromine / Q000627:therapeutic use; D014439:Tyramine / Q000378:metabolism
D000928:Antidepressive Agents; D001549:Benzamides; D007527:Isoenzymes; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D014191:Tranylcypromine; D008995:Monoamine Oxidase; D020912:Moclobemide; D014439:Tyramine
Moclobemid.